CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2023—Siemens Healthineers signed a global OEM agreement on hemostasis products with Sysmex Corp. Under the multiyear agreement, the companies will individually distribute their combined portfolio of hemostasis instruments and reagents worldwide under their respective brands.
“Siemens Healthineers and Sysmex have built a solid hemostasis partnership for more than 25 years. The time has come to offer one of the world’s most extensive product portfolios achieved through mutual OEM supply to benefit customers and patients worldwide,” Sharon Bracken, head of diagnostics for Siemens, said in a press statement. “With the OEM agreement, we will more effectively deliver quality and comprehensive hemostasis testing solutions to laboratories of all sizes across the world.”
The two companies provide hemostasis products used in testing for blood clotting disorders, preoperative bleeding risk management, and monitoring patients who are receiving anticoagulant therapy medications, among other products.